Evidence map›Paper›PMID 26490858›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

A Post-Docking Role of Synaptotagmin 1-C2B Domain Bottom Residues R398/399 in Mouse Chromaffin Cells.

Girish H Kedar, Anders S Munch, Jan R T van Weering, Jörg Malsam, Andrea Scheutzow, Heidi de Wit, Sébastien Houy, Bassam Tawfik, Thomas H Söllner, Jakob B Sørensen and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Mutations of Single Residues in the Complexin N-terminus Exhibit Distinct Phenotypes in Synaptic Vesicle Fusion.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Mechanism of neurotransmitter release coming into focus.Protein science : a publication of the Protein Society · 2018
    Review
  9. Synaptotagmin-1 drives synchronous CaNature neuroscience · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Extension of Helix 12 in Munc18-1 Induces Vesicle Priming.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 6 countries.

Girish H KedarDepartment of Functional Genomics and.ORCID http://orcid.org/0000-0002-2767-6815
Anders S MunchNeurosecretion Group, Signaling Laboratory, Department of Neuroscience and Pharmacology and Center for Biomembranes in Nanomedicine, University of Copenhagen, DK-2200 Copenhagen N, Denmark, and.
Jan R T van WeeringDepartment of Clinical Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit (VU) and VU Medical Center (VUmc), 1081 HV, Amsterdam, The Netherlands.
Jörg MalsamHeidelberg University Biochemistry Center, D-69120 Heidelberg, Germany.
Andrea ScheutzowHeidelberg University Biochemistry Center, D-69120 Heidelberg, Germany.
Heidi de WitDepartment of Clinical Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit (VU) and VU Medical Center (VUmc), 1081 HV, Amsterdam, The Netherlands.
Sébastien HouyNeurosecretion Group, Signaling Laboratory, Department of Neuroscience and Pharmacology and.
Bassam TawfikNeurosecretion Group, Signaling Laboratory, Department of Neuroscience and Pharmacology and.ORCID http://orcid.org/0000-0003-1193-8494
Thomas H SöllnerHeidelberg University Biochemistry Center, D-69120 Heidelberg, Germany.
Jakob B SørensenNeurosecretion Group, Signaling Laboratory, Department of Neuroscience and Pharmacology and Center for Biomembranes in Nanomedicine, University of Copenhagen, DK-2200 Copenhagen N, Denmark, and.ORCID http://orcid.org/0000-0001-5465-3769
Matthijs VerhageDepartment of Functional Genomics and Department of Clinical Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit (VU) and VU Medical Center (VUmc), 1081 HV, Amsterdam, The Netherlands, matthijs@cncr.vu.nl.
Heidelberg University · DECognitive Research (United States) · USToxicologie, Pharmacologie et Signalisation Cellulaire · FRUniversity of Copenhagen · DKGenomics (United Kingdom) · GBID Genomics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synaptotagmin-1 (Syt1) is the principal Ca(2+) sensor for vesicle fusion and is also essential for vesicle docking in chromaffin cells. Docking depends on interactions of the Syt1-C2B domain with the t-SNARE SNAP25/Syntaxin1 complex and/or plasma membrane phospholipids. Here, we investigated the role of the positively charged "bottom" region of the C2B domain, proposed to help crosslink membranes, in vesicle docking and secretion in mouse chromaffin cells and in cell-free assays. We expressed a double mutation shown previously to interfere with lipid mixing between proteoliposomes and with synaptic transmission, Syt1-R398/399Q (RQ), in syt1 null mutant cells. Ultrastructural morphometry revealed that Syt1-RQ fully restored the docking defect observed previously in syt1 null mutant cells, similar to wild type Syt1 (Syt1-wt). Small unilamellar lipid vesicles (SUVs) that contained the v-SNARE Synaptobrevin2 and Syt1-R398/399Q also docked to t-SNARE-containing giant vesicles (GUVs), similar to Syt1-wt. However, unlike Syt1-wt, Syt1-RQ-induced docking was strictly PI(4,5)P2-dependent. Unlike docking, neither synchronized secretion in chromaffin cells nor Ca(2+)-triggered SUV-GUV fusion was restored by the Syt1 mutants. Finally, overexpressing the RQ-mutant in wild type cells produced no effect on either docking or secretion. We conclude that the positively charged bottom region in the C2B domain--and, by inference, Syt1-mediated membrane crosslinking--is required for triggering fusion, but not for docking. Secretory vesicles dock by multiple, PI(4,5)P2-dependent and PI(4,5)P2-independent mechanisms. The R398/399 mutations selectively disrupt the latter and hereby help to discriminate protein regions involved in different aspects of Syt1 function in docking and fusion. SIGNIFICANCE STATEMENT: This study provides new insights in how the two opposite sides of the C2B domain of Synaptotagmin-1 participate in secretory vesicle fusion, and in more upstream steps, especially vesicle docking. We show that the "bottom" surface of the C2B domain is required for triggering fusion, but not for docking. Synaptotagmin-1 promotes docking by multiple, PI(4,5)P2-dependent and PI(4,5)P2-independent mechanisms. Mutations in the C2B bottom surface (R398/399) selectively disrupt the latter. These mutations help to discriminate protein regions involved in different aspects of Synaptotagmin-1 function in docking and fusion.

Indexed as

AnimalsCalciumCells, CulturedChromaffin CellsEmbryo, MammalianFemaleMaleMembrane FusionMiceMice, TransgenicMicroscopy, ConfocalMicroscopy, ElectronMutationPatch-Clamp TechniquesProtein Structure, TertiarySecretory PathwayCalciumSNARE ProteinsSynaptotagmin ISyt1 protein, mousemouse chromaffin cellspatch-clamp techniquesynaptotagmin-1ultrastructural analysis

Identifiers

PMID26490858
PMCPMC6605428
OpenAlexW2305169796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.